New patent expiration for Almatica drug GRALISE
Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It […]
Patent Expiration
New patent expiration for Baudax drug ANJESO
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There
New patent expiration for Acorda drug INBRIJA
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It
New patent expiration for Boehringer Ingelheim drug OFEV
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
New patent expiration for Boehringer Ingelheim drug OFEV Read Post »
New patent expiration for Msd Sub drug ZOLINZA
Annual Drug Patent Expirations for ZOLINZA Zolinza is a drug marketed by Msd Sub Merck and is included in one
Drug Patent Expirations for the Week of February 18, 2024
AURYXIA (ferric citrate) Keryx biopharms Patent: 9,050,316 Expiration: Feb 18, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 18, 2024 Read Post »
New patent expiration for Aquestive drug EXSERVAN
Annual Drug Patent Expirations for EXSERVAN Exservan is a drug marketed by Aquestive and is included in one NDA. It
New patent expiration for Aquestive drug EXSERVAN Read Post »
New patent expiration for Otter Pharms drug SYMPAZAN
Annual Drug Patent Expirations for SYMPAZAN Sympazan is a drug marketed by Otter Pharms and is included in one NDA.
New patent expiration for Otter Pharms drug SYMPAZAN Read Post »
New patent expiration for Sumitomo Pharma drug KYNMOBI
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sumitomo Pharma Am and is included in one
New patent expiration for Sumitomo Pharma drug KYNMOBI Read Post »
